Tests for screening and diagnosis of type 2 diabetes

Clinical Diabetes

Volumn 27, Issue 4, 2009, Pages 132-138

  Cox, Mary E ^a   Edelman, David ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

BLOOD ANALYSIS; CAPILLARY BLOOD; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRACTICE GUIDELINE; REVIEW; SCREENING;

EID: 70350150796     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.27.4.132     Document Type: Review

References (43)

1. Diabetes Public Health Resource, National Center for Chronic Disease Prevention and Health Promotion: http:// www.cdc.gov/diabetes/pubs.estimates07. htm#1. Accessed 5 June 2009
2. Harris MI, Klein R, Welborn TA, Knuiman MW: Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 15:815-819, 1992
3. Harris MI: Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16:642-652, 1993
4. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35). BMJ 321:405-412, 2000
5. DCCT Research Group: The relationship of glycemic exposure (A1C) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 44:968-983, 1995
6. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421-431, 2004
7. Muoio DM, Newgard CB: Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9:193-205, 2008
8. Tapp RJ, Zimmet PZ, Harper CA, de Courten MP, McCarty DJ, Balkau B, Taylor HR, Welborn TA, Shaw JE, Australian Diabetes Study Group: Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract 73:315-321, 2006
9. McCance DR, Hanson RL, Charles MA, Jacobsson LT, Pettitt DJ, Bennett PH, Knowler WC: Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323-1328, 1994
10. Wong TY, Klein R, Amirul Islam FM, Cotch MF, Couper DJ, Klein BE, Hubbard LD, Sharrett AR: Three-year incidence and cumulative prevalence of retinopathy: the Atherosclerosis Risk in Communities study. Am J Ophthalmol 143:970-976, 2007
11. American Diabetes Association: Standards of medical care in diabetes-2009. Diabetes Care 32 (Suppl. 1):S13-S61, 2009
12. Engelgau MM, Narayan KM, Herman WH: Screening for type 2 diabetes. Diabetes Care 23:1563-1580, 2000
13. Maynard JD, Rohrscheib M, Way JF, Nguyen CM, Ediger MN: Noninvasive type 2 diabetes screening: superior sensitivity to fasting plasma glucose and A1C. Diabetes Care 30:1120-1124, 2007
14. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436-472, 2002
15. Kolberg J, Jørgensen T, Gerwien R, Hamren S, McKenna M, Moler E, Rowe M, Urdea M, Xu X, Hansen T, Pedersen O, Borch-Johnsen K: Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 32:1207-1212, 2009
16. Gohdes D, Amundson H, Oser CS, Helgerson SD, Harwell TS: How are we diagnosing cardiometabolic risk in primary care settings? Prim Care Diabetes 3:29-35, 2009
17. Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH: Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 27:9-12, 2004
18. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
19. International Expert Committee: International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1-8, 2009
20. Barr RG, Nathan DM, Meigs JB, Singer DE: Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 137:263-272, 2002
21. McIntyre S, Crowther CA, Hiller JE, McPhee AJ: Lag times between blood sampling, spinning and plasma glucose estimation. Aust N Z J Obstet Gynaecol 37:286-288, 1997
22. American Diabetes Association: Tests of glycemia in diabetes. Diabetes Care 26 (Suppl. 1):S106-S108, 2003
23. Kim KS, Kim SK, Lee YK, Park SW, Cho YW: Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects. Diabet Med 25:997-1000, 2008
24. Cheng C, Kushner H, Falkner BE: The utility of fasting glucose for detection of prediabetes. Metab Clin Exper 55:434-438, 2006
25. Tapp RJ, Zimmet PZ, Harper CA, McCarty DJ, Chitson P, Tonkin AM, Soderberg S, Taylor HR, Alberti KG, Tuomilehto J, Shaw JE: Six year incidence and progression of diabetic retinopathy: results from the Mauritius diabetes complication study. Diabetes Res Clin Pract 73:298-303, 2006
26. Sorkin JD, Muller DC, Fleg JL, Andres R: The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28:2626-2632, 2005
27. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB: A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 93:2447-2453, 2008
28. Ziemer DC, Kolm P, Foster JK, Weintraub WS, Vaccarino V, Rhee MK, Varughese RM, Tsui CW, Koch DD, Twombly JG, Narayan KM, Phillips LS: Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med 23:528-535, 2008
29. Rushforth NB, Miller M, Bennett PH: Fasting and two-hour post-load glucose levels for the diagnosis of diabetes: the relationship between glucose levels and complications of diabetes in the Pima Indians. Diabetologia 16:373-379, 1979
30. Ko GT, Chan JC, Woo J, Lau E, Yeung VT, Chow CC, Cockram CS: The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors. Ann Clin Biochem 35:62-67, 1998
31. 31DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621, 1999 (Pubitemid 29391424)
32. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A: Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med 295:417-420, 1976
33. National Glycated Hemoglobin Standardization Project. http://www.ngsp. org/prog/index.html. Accessed 10 May 2009
34. Davidson MB, Schriger DL, Peters AL, Lorber B: Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281:1203-1210, 1999
35. Rohlfing CL, Little RR, Wiedmeyer HM, England JD, Madsen R, Harris MI, Flegal KM, Eberhardt MS, Goldstein DE: Use of GHb (A1C) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 23:187-191, 2000
36. Buell C, Kermah D, Davidson MB: Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 30:2233-2235, 2007
37. Bennett CM, Guo M, Dharmage SC: HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 24:333-343, 2007
38. Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD; Early Diabetes Intervention PROGRAM Study Group: A1C measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose. Diabetes Care 24:465-471, 2001
39. Little RR, England JD, Wiedmeyer HM, McKenzie EM, Pettitt DJ, Knowler WC, Goldstein DE: Relationship of glycosylated hemoglobin to oral glucose tolerance: implications for diabetes screening. Diabetes 37:60-64, 1988
40. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL: Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260:2864-2871, 1988
41. Saydah S, Tao M, Imperatore G, Gregg E: Glycated hemoglobin level and subsequent mortality among adults in the U.S. Diabetes Care 32:1440-1446, 2009
42. Miller CD, Barnes CS, Phillips LS, Ziemer DC, Gallina DL, Cook CB, Maryman SD, El-Kebbi IM: Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care 26:1158-1163, 2003
43. Tamborlane WV, Kollman C, Steffes MW, Ruedy KJ, Dongyuan X, Beck RW, Chase P, Fox LA, Wilson DM, Tsalikian E; The Diabetes Research in Children Network Study Group: Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes 6:13-16, 2005